Literature DB >> 16215723

Ischaemic cholangiopathy and sickle cell disease.

Mansoor Ahmed1, Moira Dick, Giorgina Mieli-Vergani, Phil Harrison, John Karani, Anil Dhawan.   

Abstract

We report a case of a 6-year-old girl of Afro-Caribbean origin, known to have sickle cell disease (SCD), with recurrent history of jaundice and abdominal pain. She was extensively investigated, including endoscopic retrograde cholangiopancreatography (ERCP), which revealed diffuse cholangiopathy of both extrahepatic and intrahepatic bile ducts. A pigtail stent was placed and balloon dilatation was performed for stricture of the extrahepatic duct. Since then, she remains well and asymptomatic. We suggest that cholangiopathy is the consequence of sickling in the end arteries of the biliary arterial tree.

Entities:  

Mesh:

Year:  2005        PMID: 16215723     DOI: 10.1007/s00431-005-0005-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  Cholangiopathy and intrahepatic stones in sickle cell disease: coincidence or ischemic cholangiopathy?

Authors:  S Hillaire; C Gardin; A Attar; M Attassi; B Terris; J Belghiti; C Degott; S Erlinger; D Valla
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

2.  Autoimmune liver disease and sickle cell anemia in children: a report of three cases.

Authors:  E Chuang; E Ruchelli; A E Mulberg
Journal:  J Pediatr Hematol Oncol       Date:  1997 Mar-Apr       Impact factor: 1.289

Review 3.  Cholangitis associated with paroxysmal nocturnal hemoglobinuria: another instance of ischemic cholangiopathy?

Authors:  D Le Thi Huong; D Valla; D Franco; B Wechsler; A De Gramont; A Auperin; P Godeau
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

Review 4.  Hepatobiliary system in sickle cell disease.

Authors:  T T Schubert
Journal:  Gastroenterology       Date:  1986-06       Impact factor: 22.682

5.  Large-vessel occlusion in sickle cell disease: pathogenesis, clinical consequences, and therapeutic implications.

Authors:  R B Francis
Journal:  Med Hypotheses       Date:  1991-06       Impact factor: 1.538

6.  Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?

Authors:  J Ludwig; C H Kim; R H Wiesner; R A Krom
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

  6 in total
  6 in total

Review 1.  Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model.

Authors:  Tirthadipa Pradhan-Sundd; Gregory J Kato; Enrico M Novelli
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-27       Impact factor: 5.282

2.  Sickle cell cholangiopathy: an endoscopic retrograde cholangiopancreatography evaluation.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed Al-Salem
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

Review 3.  Clinical management of sickle cell liver disease in children and young adults.

Authors:  Eirini Kyrana; David Rees; Florence Lacaille; Emer Fitzpatrick; Mark Davenport; Nigel Heaton; Sue Height; Marianne Samyn; Fulvio Mavilio; Valentine Brousse; Abid Suddle; Subarna Chakravorty; Anita Verma; Girish Gupte; Marki Velangi; Baba Inusa; Emma Drasar; Nedim Hadzic; Tassos Grammatikopoulos; Jonathan Hind; Maesha Deheragoda; Maria Sellars; Anil Dhawan
Journal:  Arch Dis Child       Date:  2020-11-11       Impact factor: 3.791

4.  Klatskin-like lesions.

Authors:  M P Senthil Kumar; R Marudanayagam
Journal:  HPB Surg       Date:  2012-06-28

5.  ERCP in Patients With Sickle Cell Disease: Diagnostic and Therapeutic Dilemmas.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-03-20

Review 6.  Hepatobiliary Manifestations of Sickle Cell Anemia.

Authors:  Hussain Issa; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.